Pdax S 250mg/125mg Injection
Marketer
Pharma Drugs & Chemicals
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Pdax S 250mg/125mg Injection
Cefixime and Sulbactam 250mg/125mg Injection is a dual-action antibiotic. This medication combats various bacterial infections by inhibiting microbial growth and propagation. Administration must be overseen by a medical professional. Strictly adhere to the prescribed dosage schedule; complete the entire course, even with symptom improvement. Premature cessation can compromise treatment efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, edema, respiratory distress) require urgent medical care. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occur. Sufficient rest, a balanced diet, and ample hydration will support recovery. Your doctor may order tests to monitor the medication's effects.
Primary Ingredients of Pdax S 250mg/125mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Pdax S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Pdax S 250mg/125mg Injection:
Administering this medication will be done by your physician or their registered nurse; self-medication is strictly prohibited.
Common Side effects of Pdax S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Pdax S 250mg/125mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strongly discouraged.
How Pdax S 250mg/125mg Injection works:
The injectable formulation Pdax S (250mg/125mg Ceftriaxone/Sulbactam) unites a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's antibacterial action stems from its disruption of bacterial cell wall synthesis. Sulbactam, meanwhile, counters bacterial resistance mechanisms, thus optimizing Ceftriaxone's efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Pdax S 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Pdax S (250mg/125mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Pdax S 250mg/125mg Injection necessitates careful consideration during lactation. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The injection Pdax S 250mg/125mg can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Pdax S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The injectable medication, Pdax S 250mg/125mg, requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Seek medical advice. Altering the Pdax S 250mg/125mg Injection dosage is unnecessary for patients experiencing mild to moderate liver dysfunction.
What if you forget to take Pdax S 250mg/125mg Injection :
Omit a Pdax S 250mg/125mg Injection dose? Seek your physician's advice.
Facts to Know About Pdax S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently